(DXSB) Xtrackers - Stoxx Global - Ratings and Ratios
High Dividend Stocks, Swap Agreements, Managed Investment
Description: DXSB Xtrackers - Stoxx Global
The Xtrackers - Stoxx Global Select Dividend100 Swap UCITS ETF is a German-based exchange-traded fund that tracks the Morningstar Global High Dividend Yield Index. It is designed to provide investors with exposure to a diversified portfolio of high-dividend-yielding stocks from around the world.
As a Global Equity Income ETF, DXSB focuses on delivering regular income to investors through a basket of high-quality, dividend-paying stocks. The funds underlying index, Morningstar Gbl High Div Yld NR USD, is likely to comprise a mix of established companies with a history of stable dividend payments, potentially including real estate investment trusts (REITs), utilities, and other income-generating sectors.
Analyzing the available technical data, we can observe that the ETFs price is currently near its 20-day simple moving average (SMA20) of 29.57, indicating a relatively stable short-term trend. The 50-day and 200-day SMAs are also close to the current price, suggesting a lack of strong momentum in either direction. The average true range (ATR) is relatively low at 0.23, equivalent to 0.78% of the current price, indicating moderate volatility.
Considering the fundamental data, the funds assets under management (AUM) stand at approximately 677.60 million EUR, which is a reasonable size for an ETF of this type. A larger AUM can contribute to lower expense ratios and increased liquidity.
Based on the available data, a forecast for DXSB could be constructed by analyzing the interplay between technical and fundamental factors. If the global economy continues to experience moderate growth, its likely that high-dividend-yielding stocks will remain attractive to income-seeking investors, potentially driving the ETFs price higher. However, if interest rates rise significantly, the relative appeal of dividend yields may be diminished, potentially leading to a decline in the ETFs price. Given the current technical and fundamental landscape, a reasonable forecast for DXSB could be a gradual appreciation towards 31.00 over the next 6-12 months, assuming stable market conditions and continued demand for high-dividend-yielding stocks.
Additional Sources for DXSB ETF
DXSB ETF Overview
Market Cap in USD | 795m |
Category | Global Equity Income |
TER | 0.50% |
IPO / Inception | 2007-06-01 |
DXSB ETF Ratings
Growth Rating | 54.7 |
Fundamental | - |
Dividend Rating | 46.0 |
Rel. Strength | -18.2 |
Analysts | - |
Fair Price Momentum | 29.06 EUR |
Fair Price DCF | - |
DXSB Dividends
Dividend Yield 12m | 4.49% |
Yield on Cost 5y | 6.59% |
Annual Growth 5y | 4.77% |
Payout Consistency | 90.1% |
Payout Ratio | % |
DXSB Growth Ratios
Growth Correlation 3m | 74.7% |
Growth Correlation 12m | 56% |
Growth Correlation 5y | 56.1% |
CAGR 5y | 8.44% |
CAGR/Max DD 5y | 0.49 |
Sharpe Ratio 12m | 1.00 |
Alpha | -2.35 |
Beta | 0.469 |
Volatility | 10.18% |
Current Volume | 12.9k |
Average Volume 20d | 17.2k |
Stop Loss | 29 (-3.6%) |
As of July 12, 2025, the stock is trading at EUR 30.09 with a total of 12,865 shares traded.
Over the past week, the price has changed by +0.84%, over one month by +0.97%, over three months by +14.46% and over the past year by +6.55%.
Partly, yes. Based on ValueRay´s Analyses, Xtrackers - Stoxx Global (XETRA:DXSB) is currently (July 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 54.69 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of DXSB is around 29.06 EUR . This means that DXSB is currently overvalued and has a potential downside of -3.42%.
Xtrackers - Stoxx Global has no consensus analysts rating.
According to our own proprietary Forecast Model, DXSB Xtrackers - Stoxx Global will be worth about 32.5 in July 2026. The stock is currently trading at 30.09. This means that the stock has a potential upside of +8.14%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 32.5 | 8.1% |